Emma Hardy

My hon. Friend is always very dedicated to DEFRA-related issues, and it is always nice to see her here. I will check to see whether I can give her a more detailed decision on timing—if I cannot do so in this meeting, I will ensure that I let her know afterwards. As I said, the VMD is developing the evidence base and has commissioned scientific research to investigate how these substances reach rivers and streams. It is working closely with stakeholders to collect data and address the issue. It is supporting calls for a review of the internationally agreed environmental risk assessment standards. The VMD and the Environment Agency are working closely together to understand the risks posed by these chemicals and to respond appropriately. To further address this issue, the group on pharmaceuticals in the environment has developed a road map for reducing levels of two veterinary substances in UK surface waters. The priority for this road map is to raise awareness and improve pet owner education on risks and appropriate use—I know that point has come up here. Once finalised, that road map would be available to all stakeholders. As unresearched policies can fail badly, any changes we implement must be evidence based and measurable to achieve success. This Government will not turn the other way or continue to allow our rivers, lakes and seas to be polluted. Through the Water (Special Measures) Act 2025, the independent Water Commission, future legislation and many other actions, we are demonstrating our commitment to a comprehensive reset of the water industry and will drive long-term transformative change. We remain dedicated to addressing the environmental impact of veterinary medicines, and will continue working with relevant stakeholders to find solutions that protect both animal health and the environment. I again congratulate the hon. Member for Tiverton and Minehead on securing the debate. The public want clean water and we are determined to deliver it. Question put and agreed to.